BARACLUDE .5 mg/1 (Entecavir TABLET, FILM COATED) .5 mg/1

Baraclude .5 mg is an oral medication used to manage chronic hepatitis B. This film-coated tablet contains entecavir, a potent antiviral agent. Learn more about its uses and effects.

Strength

.5 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0003-1611-12) / 30 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

E.R. Squibb & Sons, L.L.C.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Baraclude .5 mg is primarily used for the treatment of chronic hepatitis B in adults. It works by reducing the amount of hepatitis B virus in the body, helping to manage the condition. Patients often wonder, 'What is Baraclude used for?' This medication is designed to support liver health and control viral replication.

Side Effects

Common effects of Baraclude .5 mg may include headaches, dizziness, and fatigue. Some users also report nausea or diarrhea. These effects can vary from person to person, and it's important to monitor how the body responds to the medication.

Precautions & Warnings

Baraclude .5 mg should be handled with care. It is essential to follow the prescribed dosage and administration instructions. Patients with kidney problems should consult their healthcare provider before starting this medication. Always store Baraclude in a cool, dry place away from direct sunlight.

Avoid Interactions

Baraclude .5 mg may interact with other medications, including certain antiviral drugs and immunosuppressants. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Baraclude is used to manage chronic hepatitis B by reducing the amount of virus in the body.

Baraclude .5 mg is taken orally, typically once daily. Follow your healthcare provider's instructions for the best results.

Common side effects may include headaches, dizziness, fatigue, nausea, and diarrhea.

Consult your healthcare provider before consuming alcohol while on Baraclude.

Store Baraclude in a cool, dry place away from direct sunlight and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.